Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Women First co-promotes Ortho-McNeil's contraceptive and HRT

Executive Summary

Women First HealthCare (focus on health issues of mid-life women) will co-promote in the US two products for J&J company Ortho-McNeil Pharmaceutical: Ortho Tri-Cyclen (norgestimate/ethinyl estradiol) contraceptive tablets (marketed) and a combination hormone replacement therapy (under FDA review).
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Promotion
    • Marketing (Licensing)

Related Companies